-
Media Room Article
First FDA Approval of Therapeutic Cancer Vaccine a Milestone Victory for Cancer Immunotherapy
CRI celebrates yesterday’s announcement of the first therapeutic cancer vaccine to receive approval from the U.S. Food…
-
Media Room Article
Scientists Develop Novel Technology to Assess Cancer Vaccine-Induced CD4+ T-cell Response
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool…
-
Media Room Article
2010 Grace Award Winners Announced
CRI announced today that it will present fashion designer Michael Kors and GlaxoSmithKline CEO Andrew Witty with…
-
Media Room Article
CT45, an Unexpected Link Between Hodgkin Lymphoma and Reproductive Germ Cells
In a paper published in the Proceedings of the National Academy of Sciences earlier this month, the…
-
Media Room Article
Targeting Normal Cells in Tumors Slows Cancer Growth
CRI-funded scientists and their colleagues demonstrate that targeting normal cells that surround cancer cells within and around…
-
Media Room Article
Hundreds of Genes Distinguish Patients Likely to Survive Advanced Melanoma
In a recently published paper, researchers led by CRI-funded clinical investigator Dr. Nina Bhardwaj, director of the…
-
Media Room Article
HPV Vaccine Clears Viral Infection and May Reduce Cancerous Lesions
A new vaccine designed by CRI-funded investigator Dr. Cornelis Melief to stimulate an immune response against a…
-
Media Room Article
Unusual Bacteria Help Balance the Immune System in Mice
An international collaboration co-led by scientists at NYU Langone Medical Center, including CRI postdoctoral fellow Nicolas Manel,…
-
Media Room Article
CRI Announces Winner of 2009 Frederick Alt Award for New Discoveries in Immunology
CRI has announced that Anjana Rao, PhD, professor of pathology at the Harvard Medical School in Boston,…
